A systematic study uncovering multiple new and unusual bacterial immune defence mechanisms could pave the way toward new biotech tools.
To help you plan your visit, or perhaps inspire you to sign up for your free place, we’ve put together a handy guide to this year’s theme, and some of our top picks from the agenda.
The FDA has approved the very first algorithm that monitors a patient’s vitals to help predict sudden death from heart attacks or respiratory failure.
Although very much disagreeing with biohacking practices, and strongly discouraging them, the FDA has never actually intervened themselves with individuals. Should they?
In a scientific first, researchers turned skin cells from mice into stem cells by activating a specific gene in the cells using CRISPR technology.
With the possibility that CRISPR-Cas9 could prove ineffective in humans, there was talk that the stocks of these biotechs could turn out to be worthless. But the cart got before the horse — by a few miles.
This year we can expect to see large numbers of CRISPR gene-editing trials, but some are still afraid of this amazing technology.
All on its own, the presence of SRY can make a female turn out to be essentially male—with bigger muscles, a penis, and testicles (although unable to make sperm).
Sinogene, a biotech company based in Beijing has cloned a gene-edited dog in an attempt to treat cardiovascular disease.
Scientists have for the first time used CRISPR to disable a defective gene that causes amyotrophic lateral sclerosis, or Lou Gehrig’s disease, in mice, extending their lifespan by 25 percent.